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Quality of lifeObjectives: To assess symptoms of post-traumatic stress disorder, anxiety, depression and health related
quality of life in a sample of adult patients treated with veno-arterial extracorporeal membrane oxygena-
tion.
Design and setting: This is a cross-sectional study. The populationwere all patients discharged (2008–2018)
from a thoracic surgical intensive ward at a tertiary university hospital in Norway. A sample of 20 patients
was recruited.
Main outcome measures: Symptoms of post-traumatic stress disorder were assessed using Impact of Events
Scale-Revised, while symptoms of depression and anxiety were assessed using Hospital Anxiety and
Depression Scale. RAND36-ItemShort FormHealth Surveywas applied tomeasure health-relatedquality of life.
Results: Symptoms of post-traumatic stress disorder were reported by 40% of the participants. Twenty per-
cent reported symptoms of depression and anxiety. Compared to the general population, participants
reportedpoorer health-related quality of life on all domains, and significantlyworseon the domains physical
function, general health and social function.
Conclusion: Patients in our study reported symptoms of post-traumatic stress disorder, anxiety, depression
and impairedhealth-related quality of life following treatmentwith veno-arterial extra corporealmembrane
oxygenation. Addressing possible emotional and psychological distress could represent a potential major
improvement in health care provided to this group. Further research is needed to incorporate prophylactic
methods, such as identifying vulnerable patients and implement corresponding interventions, into clinical
practice.
 2021 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Implications for clinical practice
 This study reports of impaired health-related quality of life and increased prevalence of self-reported symptoms of PTSD, anxiety and
depression after veno-arterial extracorporeal membrane oxygenation treatment.
 Our findings, combined with prior research, illustrate the need for preventive clinical practice and follow-up from critical care nurses
and other health care professionals.
 Patient-reported outcome data may contribute to the development of interventions that prevent long-term complications and
improve overall health status after veno-arterial extracorporeal membrane oxygenation treatment.
Fig. 1. Inclusion flowchart.
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Veno-arterial extracorporeal membrane oxygenation (VA
ECMO) is a highly effective therapy given to critically ill patients
requiring temporary cardiac and/or respiratory support. Advances
in ECMO technology, combined with reports of positive treatment
outcomes, have led to increased use of ECMO the last decade
(Mosier et al., 2015; Extracorporeal Life Support Organization,
2019). Among patients treated with ECMO, approximately 40 per-
cent survives to discharge from hospital (Extracorporeal Life
Support Organization, 2019). The majority of studies on long-
term outcome of ECMO-treatment has focused mainly on survival
rates and somatic health variables. However, the unique risk fac-
tors specifically associated with ECMO-treatment, can affect
patients in a longer time span and on domains other than survival
and ‘‘pure” somatic health, resulting in potential impaired quality
of life and mental health for the survivors (Roll et al., 2018;
Spangenberg et al., 2018). Research that increases knowledge
about patient-reported outcomes, in this case following VA
ECMO-treatment, may contribute to the development of measures
that prevent long-term complications, and furthermore improves
overall health status after discharge from hospital.
VA ECMO-treatment requires resource demanding intensive
care and follow-up. Patients treated with VA ECMO have reported
lower perceived quality of life than the general population
(Mirabel et al., 2011; Muller et al., 2016; Corsi et al., 2017;
Tramm et al., 2017). In addition, symptoms of post-traumatic
stress disorder (PTSD), depression and anxiety seem prevalent
(Mirabel et al., 2011; Chen et al., 2016; Muller et al., 2016; Corsi
et al., 2017; Tramm et al., 2017). Based on this notion, the aim of
this study was to describe health-related quality of life (HRQoL)
and assess symptoms of post-traumatic disorder (PTSD), anxiety
and depression in a sample of VA ECMO-treated patients. A second
aim was to identify clinical and demographic factors associated
with these patient perceived outcomes. We conducted a cross-
sectional single center study to investigate the prevalence and cor-
relation between reported symptoms of post-traumatic reactions,
anxiety, depression and health-related quality of life in patients
treated with VA ECMO at Haukeland University Hospital, Norway.Methodology
Participants and data collection
Survivors after VA ECMO-treatment were identified from the
hospital database and retrospectively analysed. All participants
included in the study were 18 years or older and treated with VA
ECMO at Haukeland University hospital during the period from
2008 to June 2018. A prerequisite was that all participants had to
be fluent in Norwegian. Totally 108 patients were treated with
VA ECMO during the inclusion period, 43 (40%) were still alive at
the time of recruitment in January 2019. Of these, 13 did not fulfil
the inclusion criteria due to treatment after cut-off point, lower
age, unknown address or inability to understand Norwegian
(Fig. 1). The participants were recruited through an invitation to
take part in the study by postal mail. A reminder was sent to
non-responders three weeks after the first invitation. The final
response rate was 20 (67%) of the 30 eligible patients.Assessments
Sample characteristics such gender, age, marital status, children,
and education level were provided by the participants, as well as
working capacity and need for assistance in daily life before and
after VA ECMO-treatment. Clinical data such as primary diagnosis2
requiring ECMO-treatment, duration of ECMO-treatment, time
lapse since ECMO, and finally if the intensive care unit kept diary
during treatment on the patient́s behalf or not, were retrieved from
the hospital databases.
Post-traumatic stress disorder. Symptoms of post-traumatic
stress disorder (PTSD) were assessed using the Impact of Events
Scale- Revised (IES-R). The instrument contains 22 questions with
three different subscales that measure the intensity of fragmented
and intrusive memory image (8 items), present autonomous
hyperactivation (6 items) and avoidance behaviour (8 items). IES-
R has a 4-point Likert scale (range 0–4) resulting in a possible score
ranging from 0 (none) to 88 (Weiss, 2007). A total score higher
than 33 (cut-off > 33) has been reported to indicate presence of
probable severe PTSD (Creamer et al., 2003), while scores ranging
from 24 to 32 indicate the possibility of moderate PTSD-
symptomatology (McCabe, 2019).
Anxiety and depression. Symptoms of anxiety and depression
were assessed using The Hospital Anxiety and Depression Scale
(HADS). This is a 14-item questionnaire. Half of the questions aims
to assess anxiety, whereas the other half assesses depression. The
questionnaire uses a 4-point Likert scale (range 0–3) producing a
minimum score of 0 (none symptoms of anxiety or depression)
and a maximum score of 21 for each subscale, representing severe
symptoms of either anxiety, depression or both
(Folkehelseinstituttet, 2016). A subscale score of 8–10 indicates a
possible need for further follow-up while a score of  11 is an indi-
cation of severe psychological distress, possible need for follow- up
and treatment. On both dimensions combined, a HADS total score
of  15 indicates need for closer follow-up and treatment
(Zigmond and Snaith, 1983; Herrmann, 1997).
Health-related quality of life (HRQoL). HRQoL was measured
using the RAND 36-Item Short Form Health Survey (RAND-36).
This is a generic self-rating instrument identical to 36-item
short-form health survey (SF-36), and it is translated into Norwe-
gian in accordance with international guidelines for translating
Patient Reported Outcome Measures (PROMs)
(Folkehelseinstituttet, 2015). RAND-36 consist of eight domains:
general health (GH), physical function (PF), mental health (MH),
social function (SF), vitality (VT), bodily pain (BP), role physical
(RP) and role emotional (RE). Answers on the domains were trans-
formed into scale scores from 0 to 100, where higher score indicate
better perceived HRQoL (Ware Jr and Sherbourne, 1992).
The instruments have shown satisfactory validated psychomet-
ric properties (Herrmann, 1997; Ware, 2000; Weiss, 2007; Eid
et al., 2009; Folkehelseinstituttet, 2015).
RAND-36 scores from our patients were compared to Norwe-
gian reference values on the SF-36. These reference values were
Table 1
Demographic and clinical characteristics of the responders and non-responders
treated with VA ECMO.
Responders Non-responders
Male gender, n (%) 17 (85) 10 (100)
Current age, mean (min–max) 57 (29–79) 46 (35–72)
Indication VA ECMO
Post-cardiotomy 8 (40) 3 (30)
Acute Coronary Syndrome 5 (25) 2 (20)
Cardiomyopathy 3 (15) 4 (40)
Myocarditis 3 (15) 0 (0)
Hypothermia 2 (10) 1(10)
Other 1 (5) 0 (0)
Educational level, n (%)
Primary/high school 14 (74)
University level 5 (26)
Working pre-ECMO, n (%)
Working 12 (63)
Not working 3 (16)
Retired > 67 years 4 (21)
Working post-ECMO, n (%)
Working 8 (42)
Not working 4 (21)
Retired > 67 years 7 (37)
Living situation, n (%)
Home independent 14 (78)
Home with help 4 (22)







Hours on ECMO 101
Months since ECMO 39
Time, min-max
Hours on ECMO 25–238
Months since ECMO 11–128
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among the general Norwegian population (Jacobsen et al., 2018).
Statistical analysis
Descriptive statistics include mean, standard deviation, median
andmin/max for numerical variables, and frequencies and percent-
ages for categorical data, with 95% confidence intervals. Missing
answers on two IES-R items from one participant were handled
by averaging answers from the remaining 20 questions. This is in
line with Creamer and colleagues’ recommendations (Creamer
et al., 2003).
Due to lack of symmetric distribution and limited number of
participants, the associations between demographic and clinical
variables and RAND 36, IES and HADS were analysed using the
non-parametric correlation test Spearman’s rho.
The internal consistency (Chronbach’s alpha) of the self-
reported questionnaires ranged from 0,602 on the RAND 36 Gen-
eral Health domain to 0,936 in the Role Emotional domain. Wil-
coxon signed rank tests were applied to compare the RAND 36
scores reported by VA ECMO patients with age and gender
matched expected SF-36 scores from the Norwegian general popu-
lation data (Jacobsen et al., 2018). Multivariate analysis was not
conducted due to the small sample size. All analyses were per-
formed using the SPSS version 24 (IBM, Statistical Package for
Social Sciences).
Ethics
Informed written consents were obtained from all participants.
Approval of the study was given by the Cardiac Unit and registered
at the Data Protection Officery, both at Haukeland University
Hospital. Ethical approval was obtained from the Regional Com-
mittees for Medical and Health Research Ethics south-east (REC
approval No.: 2018/1872). A contingency plan was developed for
those of the participants with severe symptom of PTSD, anxiety
and depression. Return postage-paid envelopes were provided to
participants. No other financial incentives were given.Results
Mean age of the participants was 57 years and 17 (85%) out of
20 participants were men. The main indication for VA ECMO was
found to be post-cardiotomy heart failure, but a high proportion
of other indications was also present (Table 1). Time lapse since
treatment varied between 11 months and 10 years (mean
39.4 months), and duration of VA ECMO varied between 25 and
238 h (mean 101 h). In terms of vocational status only one partic-
ipant who had been working prior to admission did not return to
active labour following ECMO-treatment. Hence, the main reason
not to return to active work was retirement due to age. All partic-
ipants lived at home and the majority (78%) did not need practical
or medical assistance from health care services or family in their
daily life. Intensive care diary was provided to eight (40%) of the
participants. Impaired mobility, visual impairment and pain in
the back and lower extremity were complications reported by sev-
eral of the participants.
Due to small sample size we were unable to observe signifi-
cant associations between demographic factors, clinical factors
and outcome measures.
Symptoms of PTSD were reported by 40% of the participants
(IES- R  24) and 20% reported symptoms of severe PTSD (IES-
R  33). Avoidance behaviour were the most frequently reported
cluster of PTSD symptoms (Table 2). Twenty percent of the partic-
ipants reported symptoms of anxiety and depression combined3
which indicates a possible need for further follow-up and treat-
ment (HADS-AD scores  15). Scores on IES-R and HADS tended
to be lower for participants where the time lapse since ECMO-
treatment was longer (2,5 years).
RAND-36 HRQoL assessment results are reported in Table 3 and
in Fig. 2. Compared to the age and gender matched control group,
VA ECMO treated patients reported poorer health-related quality
of life on all domains and significantly worse on the domains phys-
ical function, general health and social function. Notably, individ-
ual reporting on physical and emotional role was also
substantially worse compared to the general population. Internal
consistency assessed by Cronbach’s alpha was found to be satisfy-
ing in all the instruments (Table 3).Discussion
Nearly half of the participants reported adverse posttraumatic
symptoms. Additionally, outcomes on HRQoL are poorer compared
to the general population and significantly lower on several
domains. Comparisons to other studies is complicated given that
our study includes patients treated with VA-ECMO regardless of
treatment indications. Based on the heterogeneity this entails
one could speculate that our group represents greater variation
prior to VA-ECMO treatment compared to studies that include par-
ticipants based on a specific diagnosis. This represents a possible
weakness when comparing with other studies (Table 4).
Table 2
Health-related quality of life and symptoms of anxiety, depression and post-traumatic stress disorder in patients treated with VA ECMO.
Form/Subscale Number of questions Total range Mean
(SD)
Median 95% CI Cronbach’s
alpha
RAND-36
PF 10 0–100 69,2 (26,6) 72,5 56,8–81,7 0,909
RP 4 0–100 57,5 (42,2) 62,5 37,7–77,3 0,883
BP 2 0–100 66,0 (21,8) 65 55,8–76,3 0,857
GH 5 0–100 62,0 (16,4) 60 54,3–69,7 0,602
VT 4 0–100 58,0 (20,9) 60 54,3–69,7 0,792
SF 2 0–100 74,3 (24,1) 75 63,1–85,7 0,733
RE 3 0–100 76,6 (20,6) 100 57,7–95,7 0,936
MH 5 0–100 79,2 (16,8) 84 71,3–87,1 0,832
HADS 14 0–42 6,9 (6,9) 3 3,6–10,1 0,914
Anxiety 7 0–21 3,8 (4,2) 2 1,8–5,7 0,890
Depression 7 0–21 3,1 (3,1) 2,5 1,7–4,5 0,799
IES-R 22 0–88 19,7 (13,7) 19 13,3–26,2 0,932
Intrusion 8 0–32 0,90 (0,69) 0,8 0,6–1,2 0,882
Hyperarousal 6 0–24 0,75 (0.63) 0,8 0,5–1 0,815
Avoidance 8 0–32 0,98 (0,65) 1,1 0,7–1,2 0,814
RAND-36: RAND 36-Item Short Form Health Survey.
PF = Physical function, RP = Role Physical, BP = Bodily pain, GH = General health, VT = Vitality, SF = Social function, RE = Role Emotional, MH = Mental health.
HADS: Hospital Anxiety and Depression Scale.
IES-R: Impact of events scale-Revised.
Table 3
RAND 36, VA ECMO vs age-and gender-matched Norwegian population.
Rand 36 VA ECMOa General populationa P-valueb
PF 69,2 (26,6) 87,7 (5,1) 0,018*
RP 57,5 (42,2) 78,5 (8,8) 0,086
BP 66.0 (21,8) 72,3 (4,4) 0,247
GH 62,0 (16,4) 73,2 (1.4) 0,021*
VT 58,0 (20,9) 61,6 (3) 0,502
SF 74,3 (24,1) 88,7 (2) 0,016*
RE 76,6 (20,6) 88,6 (3,4) 1,0
MH 79,2 (16,8) 81,7 (2,9) 0,695
PF = Physical function, RP = Role Physical, BP = Bodily pain, GH = General health,
VT = Vitality, SF = Social function, RE = Role Emotional, MH = Mental health.
a Mean scores (SD).
b Wilcoxon signed rank test.
* p-value < 0,05.
Fig. 2. RAND 36 scores of VA ECMO patients compared with age-and gender
matched expected scores from the Norwegian general population.
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The percentage of patients with moderate and high occurrence
of PTSD-symptoms in our sample are considerably elevated com-4
pared to a French study by Muller and colleagues (2016), who only
found 5% in risk of PTSD. All participants in their study received VA
ECMO following refractory cardiogenic shock, and the duration of
treatment with VA ECMO was twice as long (8 days). However, dis-
tributions on gender, age and time since treatment were similar to
our study, and do not explain the difference in the occurrence of
PTSD-symptoms. A comparable finding to ours regarding the
occurrence of PTSD-symptoms is reported in the French study by
Mirabel et al. (2011) on patients treated with ECMO due to fulmi-
nant myocarditis. 27% of the patients included were found to be at
high risk of developing PTSD. Our study found 20% at high risk,
while 40% can be classified as having a moderate risk of developing
PTSD. However, there are differences between the two samples.
Duration of ECMO treatment were quadrupled (16,2 days) in the
study by Mirabel and colleagues, their participants were on aver-
age 19 years younger and gender distribution was more equal
compared to our study. Finally, high prevalence of PTSD symptoms
is reported in a systematic study on general intensive care unit sur-
vivors, where the reported prevalence of ‘‘clinically significant”
PTSD symptoms is 22% (Davydow et al., 2009). The authors con-
clude that high prevalence of PTSD-symptoms among ICU sur-
vivors negatively impacts survivor HRQoL. A contributing factor
to the comparably high prevalence of reported symptoms of PTSD
in our study may be related to different use of cut-off on IES-R.
Both Mirabel and Muller applied a cut off  30. Our study applied
a diagnostic cut-off of  33, which indicates the presence of possi-
ble severe PTSD (Creamer et al., 2003). For our purpose it was also
desirable to identify those participants with the possibility of mod-
erate PTSD-symptomatology, hence the inclusion of patients with
scores > 22, as proposed by Stukalin et al. (2019). Notably, we
had no knowledge of the participants’ mental health-status prior
to ECMO-treatment. Nonetheless, symptoms of PTSD in our sample
were quadrupled compared to the general prevalence in the Nor-
wegian population (3.8% for men and 8.5% for women) (Heir
et al., 2019).
PTSD is often accompanied by comorbid mental health prob-
lems such as depression and anxiety (American Psychiatric
Association, 2013). Although case-mix differences make compar-
isons between studies difficult, our patients had similar or even
better HADS scores than fulminant myocarditis patients rescued
by VV or VA- ECMO (Mirabel et al., 2011) and patients treated with
VA ECMO due to acute myocardial infarction (Muller et al., 2016).
Table 4
Correlationa between demographic variables and IES-r, HADS and RAND-36.
IES-R HADT HADA HADD PF RP BP GH VT SF RE MH
Gender –,340 –,246 –,210 –,295 ,317 ,139 ,386 ,159 ,122 ,012 –,030 ,147
Age –,060 –,071 –,132 ,001 –,111 –,438 –,004 –,025 ,140 –,025 –,091 ,315
Marital status –,187 –,332 –,379 –,300 ,121 ,092 –,225 ,044 ,110 ,347 ,308 ,443
Education –,089 –,072 –,162 ,000 –,537* –,793y –,457* –,154 –,208 –,478* –,160 ,187
Working situation ,147 –,058 –,118 –,051 ,223 ,111 ,259 ,109 ,167 ,056 –,047 ,141
Months since ECMO –,067 –,049 –,008 –,074 ,039 ,018 –,252 ,020 ,051 ,158 ,205 –,065
Hours on ECMO –,042 –,209 –,190 –,184 ,137 ,046 ,035 ,186 ,478* ,304 ,283 ,474*
ICU Diary –,089 –,072 –,162 ,000 ,249 ,037 –,027 –,267 –,036 ,036 ,066 ,223
IES-R: Impact of Event Scale- Revised.
HADS: Hospital Anxiety and Depression Scale. HADT: total score, HADA: anxiety, HADD: depression.
RAND- 36: Short Form Health Survey. PF = Physical function, RP = Role Physical, BP = Bodily pain, GH = General health, VT = Vitality, SF = Social function, RE = Role Emotional,
MH = Mental health.
a Spearmans rho.
* P < 0.05.
y P < 0.001.
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reported no symptoms of depression (above cut-off > 8). Notably,
the different findings in our study compared to those of Ørbo
and colleagues may be related to more equal gender distribution
and younger participants in the latter study (mean age nine years
lower). Furthermore, previous research indicates that anxiety is the
most frequently reported mental health difficulty among VA ECMO
survivors (Mirabel et al., 2011; Muller et al., 2016; Ørbo et al.,
2019).
Reports on the effectiveness and usefulness of keeping intensive
care diaries on behalf of the patients have highlighted potential
benefits such as increased understanding of the treatment process
they have received and subsequently being able to reconstruct
memories from the course of treatment (Bäckman et al., 2010;
Jones et al., 2010). Diaries were only completed and given to 40%
of the patients in our sample. Concerning reported symptoms of
PTSD, the group difference between patients with or without dia-
ries is non-significant. This corresponds with prior research,
reporting that the potential preventive effect of the development
of post-traumatic reactions following intensive care is inconclusive
(Ullman et al., 2015; McIlroy et al., 2019). Patients with the highest
reported prevalence of PTSD symptomatology in our study were
also the ones who kept diaries. This can possibly be related to a
tendency towards keeping diaries on behalf of the patients per-
ceived by the staff to have the most severe degree of pathology,
or an interpretation of certain patients being more eligible to ben-
efit from a diary than others. On the other hand, the participants
who received a diary did report better mental health on RAND 36.HRQoL after ECMO
RAND-36 was administered to assess HRQoL among VA ECMO
survivors. Scores among our participants were higher on all
domains compared to other studies reporting HRQoL after VA
ECMO (Tramm et al., 2017; Ørbo et al., 2019), and similar to those
reported by the group of Mirabel et al. (2011) fulminant myocardi-
tis patients and the Australian study of HRQoL in both VA and VV
ECMO patients, conducted by Roll et al. (2018). Nonetheless, most
studies that have compared values from the general population to
values reported among ECMO-treated patients, report impaired
HRQoL in the latter group (Mirabel et al., 2011; Hsieh et al.,
2016; Corsi et al., 2017; Roll et al., 2018; Spangenberg et al.,
2018; Ørbo et al., 2019). This is consistent with our findings, when
comparing our results with Norwegian reference values (Jacobsen
et al., 2018). Substantial differences were found on domains mea-
suring general health, role physical and emotional, physical and
social function. This corresponds with findings reported by Roll
et al. (2018) and Mirabel et al. (2011). The restriction of physical5
function may be associated with adverse outcome. Impaired
mobility, visual impairment and pain in the back and lower
extremity are some of the complications reported in our study.
This is consistent with former literature on the complication due
to ECMO (Bartlett, 2016; Khorsandi et al., 2017; Mossadegh and
Faulkner, 2017). According to the developers of SF-36, the physical
and emotional problems in everyday living will be reflected on the
domain social function (Ware Jr and Sherbourne, 1992). Our partic-
ipants reported poor scores on this domain. Impaired social func-
tioning is a possible outcome of the combination of impaired
physical functioning and mental health difficulties (World Health
Organization, 1999; American Psychiatric Association, 2013). The
poor score on general health, both found in this study and similarly
reported by Roll et al. (2018) and Ørbo et al. (2019), is a possible
consequence of the reported symptoms of PTSD, anxiety, depres-
sion and impaired mobility combined.
The majority of our participants had VA ECMO access via a
femoral artery. This can cause reduced circulation to the affected
extremity. Mirabel et al. (2011) reports that 48% of the participants
with femoral artery cannulation had paraesthesia or peripheral
neurologic defect around or peripheral to the site of ECMO cannu-
lation. We found that, despite reports of improved physical func-
tioning over time (Tramm et al., 2017; Gerth et al., 2019),
patients with the longest time lapse since VA ECMO in our sample
reported the lowest scores on physical functioning. Recently trea-
ted patients were given a peripheral shunt when the arterial access
was in the femoral artery. This may prevent physical complications
through ensuring adequate circulation in the lower extremity and
provide a possible explanation why patients treated before this
change in clinical practice report impaired physical functioning.
Impaired physical function may also be due to aging, and not
related to VA ECMO itself. Age variations as well as other acquired
diseases may also affect physical function. Despite the reported
impairment in physical functioning, the majority of the patients
were able to manage everyday living without the assistance of
home nursing or family members.
A compelling finding in our study is the relatively good mental
health status reported by our participants measured through RAND
36. However, one cannot rule out that distress following PTSD-
symptomatology can be expressed through the poor scores on
the domain emotional role functioning and, as previously men-
tioned, on social functioning.Strengths and limitations
The main strength of our study is the findings which, combined
with results from prior research, presents implications with poten-
tially high clinical value for patients treated with VA ECMO. This
A. Kolle, E.C. Irgens, A.L. Moi et al. Intensive & Critical Care Nursing 65 (2021) 103058applies in particular to the possible benefit of being able to identify
impaired quality of life, symptoms of PTSD, anxiety and depression
among VA ECMO survivors and to recommend a corresponding
development of psychological support during recovery.
Our study is not without limitations. Firstly, it is a single center
study, consisting of a small, heterogenous sample. This is an unfor-
tunate but common problem when recruiting to studies of VA
ECMO. Due to lack of data on HRQoL and mental health status prior
to onset of VA ECMO-treatment, the result of this study could
reflect pre-existing factors not linked to the aftermaths of the pro-
cedure. Furthermore, lack of raw-data from the reference study on
HRQoL can be considered a possible bias.
Conclusion
The major finding from this study is that nearly half of the
patients in a sample of formerly VA ECMO-treated patients report
the presence of PTSD symptoms. Although to a lower degree,
reports of isolated depressive and anxiety symptoms, or the two
combined, are also present. Compared to the general population,
the participants have impaired HRQoL. Incorporating routines for
identifying patients with known vulnerability for developing PTSD
following VA ECMO-treatment, and the development of corre-
sponding preventive measures, would possibly influence post-
treatment mental health, perceived health-related quality of life
and level of functioning.
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